OpenScience.ink

3 weeks ago • Obesity reviews : an official journal of the International Association for the Study of Obesity

Using Combined Glucagon and Incretin Signals to Treat Obesity and Fatty Liver DiseaseThe Power of Two: Harnessing Dual Glucagon and Incretin Signaling for Treatment of Obesity and Metabolic Dysfunction-Associated Steatohepatitis-A Narrative Review with a Translational Focus.

Article

3 weeks ago • Biochemical pharmacology

A combined GLP-1 and apelin receptor activator may protect brain cells in a mouse model of Parkinson’s diseaseA GLP-1/apelin dual receptor agonist shows neuroprotective effects in the MPTP mouse model of Parkinson's disease.

Article

3 weeks ago • Health affairs scholar

Differences by social and demographic factors in prescribing semaglutide and tirzepatide for obesity treatmentSociodemographic disparities in semaglutide and tirzepatide prescription for obesity treatment.

Article

3 weeks ago • microPublication biology

Semaglutide lowers smell-driven movement and reproduction in roundwormsSemaglutide Reduces Odorant-Driven Chemotaxis and Reproductive Output in Caenorhabditis elegans.

Article

3 weeks ago • Journal of the American Society of Nephrology : JASN

Estimating Who Qualifies for Combined Heart and Kidney Treatment and How Many Deaths Could Be PreventedA Microsimulation of Eligibility for Cardiorenal Combination Treatment and Potential Deaths Averted.

Article

3 weeks ago • JAMA

Unapproved GLP-1 Drugs Retatrutide and Zenagamtide Sold Online May Not Be Safe or EffectiveUnapproved GLP-1 Drugs Retatrutide and Zenagamtide Sold Online Are No Bargain.

Article

3 weeks ago • Endocrine-related cancer

Effects of a GLP-1 drug and diabetes treatments on growth of certain hormone tumorsEffects of a GLP-1 agonist and anti-diabetic therapies on pheochromocytoma/paraganglioma growth.

Article

3 weeks ago • Diabetes, obesity & metabolism

GLP-1 Receptor Agonist Treatment for Blood Sugar Problems Caused by Steroid Use: A Systematic ReviewGLP-1 Receptor Agonist Therapy for Glucocorticoid-Induced Dysglycaemia: A Systematic Review.

Article

3 weeks ago • Pharmacotherapy

Incretin-like Drugs and Their Links to Alcohol-Related Problems: A ReviewIncretin Mimetics and Alcohol-Related Outcomes: A Structured Narrative Review.

Article

4 weeks ago • Diabetes, obesity & metabolism

Use of GLP-1 Receptor Agonists and Their Link to Frailty and Falls in Adults with Type 2 DiabetesAssociation of GLP1-Receptor Agonist Use With Frailty and Falls in Adults With Type 2 Diabetes.

Article

4 weeks ago • Diabetes, obesity & metabolism

How GLP-1 Treatments Affect Muscle Loss and How to Protect Lean Body MassWeight Loss or Muscle Loss? Cellular Mechanisms and Clinical Strategies for Preserving Lean Mass During GLP-1-Based Therapy.

Article

4 weeks ago • Diabetes, obesity & metabolism

Kidney health with GLP-1 drugs and tirzepatide compared to finerenone in type 2 diabetes and chronic kidney diseaseKidney Outcomes With GLP-1 Receptor Agonists and Tirzepatide Versus Finerenone in Type 2 Diabetes and Chronic Kidney Disease: A Real-World Cohort Study.

Article

4 weeks ago • Endocrine

GLP-1 Receptor Levels and Skin Diseases: Genetic Analysis and Real-World DataGLP-1R expression and dermatological diseases: a mendelian randomization and real-world study.

Article

4 weeks ago • American journal of physiology. Cell physiology

How GLP1Ra affects lean body tissue as well as fatMore than just adipose. The impact of GLP1Ra on lean tissue.

Article

4 weeks ago • Diabetes, obesity & metabolism

Effectiveness and Safety of Synthetic Semaglutide Injections for Treating Obesity in a Large Clinical TrialEfficacy and Safety of Chemically Synthesized Semaglutide Injection (HD1916) for the Treatment of Obesity: A Multicenter, Randomized, Phase III Trial.

Article

1 month ago • Peptides

Two-Way Drug Effects on the GIP Receptor in Obesity: History, Different Mechanisms, and Challenges for TreatmentBidirectional pharmacology of GIP receptor targeting in obesity: Historical foundations, mechanistic divergence, and translational boundaries.

Article

1 month ago • Reviews of physiology, biochemistry and pharmacology

Amino Acids in Obesity and Fatty Liver Disease Linked to Metabolic ProblemsAA in Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Nonalcoholic Fatty Liver Disease (NAFLD).

Article

1 month ago • Health affairs (Project Hope)

Spending Growth in a Large Massachusetts Insurer Caused by More and More Intense CareSpending Growth In A Large Massachusetts Insurer Driven By Volume And Intensity.

Article

1 month ago • Cureus

Comparing the effectiveness and safety of Liraglutide and Metformin in women with polyendocrine metabolic ovarian syndromeComparative Efficacy and Safety of Liraglutide Versus Metformin in Women With Polyendocrine Metabolic Ovarian Syndrome (PMOS): A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Article

← prevpage 16 of 16next →

GLP-1 Therapies Research Papers